Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Daxor Corporation stock logo
DXR
Daxor
$10.02
-4.6%
$9.43
$6.55
$11.21
$48.47M-0.1373,073 shs34,762 shs
Inogen, Inc stock logo
INGN
Inogen
$6.48
+10.4%
$6.69
$5.70
$13.33
$174.23M1.72223,361 shs651,610 shs
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$47.75
+2.6%
$45.15
$18.30
$70.26
$155.71M0.1945,228 shs21,906 shs
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
$4.24
+19.4%
$3.85
$2.03
$7.05
$219.19M2.44114,433 shs274,948 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Daxor Corporation stock logo
DXR
Daxor
-4.57%+6.03%+5.47%+29.29%+18.02%
Inogen, Inc stock logo
INGN
Inogen
+10.39%+4.35%-13.60%+3.85%-41.52%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
+2.62%+0.84%-2.53%+7.81%+148.44%
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
+19.44%+29.66%+20.45%+36.77%-23.05%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Daxor Corporation stock logo
DXR
Daxor
3.945 of 5 stars
3.55.00.00.02.31.70.0
Inogen, Inc stock logo
INGN
Inogen
4.099 of 5 stars
3.33.00.03.92.01.71.3
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
1.9915 of 5 stars
2.51.00.00.02.61.71.9
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
1.8858 of 5 stars
1.24.00.00.03.83.30.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Daxor Corporation stock logo
DXR
Daxor
3.00
Buy$25.00149.50% Upside
Inogen, Inc stock logo
INGN
Inogen
2.50
Moderate Buy$11.0069.75% Upside
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
3.00
Buy$56.0017.28% Upside
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
2.43
Hold$4.270.63% Upside

Current Analyst Ratings Breakdown

Latest DXR, SGHT, INGN, and PDEX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/8/2025
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$3.00 ➝ $5.00
7/15/2025
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$3.00 ➝ $4.00
6/18/2025
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$3.50 ➝ $4.00
6/16/2025
Inogen, Inc stock logo
INGN
Inogen
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$14.00
6/15/2025
Inogen, Inc stock logo
INGN
Inogen
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$14.00
5/27/2025
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
Ascendiant Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$54.00 ➝ $56.00
5/22/2025
Inogen, Inc stock logo
INGN
Inogen
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Moderate Buy$12.00
5/22/2025
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$3.20 ➝ $3.60
5/9/2025
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$2.50 ➝ $3.00
(Data available from 8/9/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Daxor Corporation stock logo
DXR
Daxor
N/AN/AN/AN/AN/AN/A
Inogen, Inc stock logo
INGN
Inogen
$335.70M0.52N/AN/A$7.30 per share0.89
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$53.84M2.89$0.96 per share49.87$9.03 per share5.29
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
$79.87M2.74N/AN/A$1.72 per share2.47
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Daxor Corporation stock logo
DXR
Daxor
N/AN/A0.00N/AN/AN/AN/AN/A
Inogen, Inc stock logo
INGN
Inogen
-$35.89M-$1.060.00N/AN/A-7.58%-14.02%-8.58%N/A
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$2.13M$2.8017.0523.18N/A14.61%29.08%16.19%9/4/2025 (Estimated)
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
-$51.51M-$0.980.00N/AN/A-64.23%-56.52%-35.33%N/A

Latest DXR, SGHT, INGN, and PDEX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
9/4/2025Q4 2025
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
$0.47N/AN/AN/A$17.90 millionN/A
8/7/2025Q2 2025
Inogen, Inc stock logo
INGN
Inogen
-$0.22-$0.15+$0.07-$0.15$90.40 million$92.28 million
8/7/2025Q2 2025
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
-$0.25-$0.23+$0.02-$0.23$18.18 million$19.56 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Daxor Corporation stock logo
DXR
Daxor
N/AN/AN/AN/AN/A
Inogen, Inc stock logo
INGN
Inogen
N/AN/AN/AN/AN/A
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
N/AN/AN/AN/AN/A
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Daxor Corporation stock logo
DXR
Daxor
N/AN/AN/A
Inogen, Inc stock logo
INGN
Inogen
N/A
3.07
2.67
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
0.28
2.73
1.45
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
0.51
10.47
9.99

Institutional Ownership

CompanyInstitutional Ownership
Daxor Corporation stock logo
DXR
Daxor
1.34%
Inogen, Inc stock logo
INGN
Inogen
89.94%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
15.28%
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
55.51%

Insider Ownership

CompanyInsider Ownership
Daxor Corporation stock logo
DXR
Daxor
59.50%
Inogen, Inc stock logo
INGN
Inogen
1.46%
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
47.50%
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
30.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Daxor Corporation stock logo
DXR
Daxor
374.84 million1.96 millionNot Optionable
Inogen, Inc stock logo
INGN
Inogen
1,03026.89 million26.49 millionOptionable
Pro-Dex, Inc. stock logo
PDEX
Pro-Dex
1403.26 million1.71 millionNot Optionable
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
21051.70 million35.72 millionOptionable

Recent News About These Companies

Sight Sciences, Inc. (SGHT) Q2 2025 Earnings Call Transcript
Sight Sciences Reports Q2 2025 Financial Results
SGHT - Sight Sciences Inc Chart - Morningstar
Sight Sciences Leads The Pack Of 3 Promising Penny Stocks

New MarketBeat Followers Over Time

Media Sentiment Over Time

Daxor stock logo

Daxor NASDAQ:DXR

$10.02 -0.48 (-4.57%)
As of 08/8/2025 04:00 PM Eastern

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.

Inogen stock logo

Inogen NASDAQ:INGN

$6.48 +0.61 (+10.39%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$6.50 +0.01 (+0.23%)
As of 08/8/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

Pro-Dex stock logo

Pro-Dex NASDAQ:PDEX

$47.75 +1.22 (+2.62%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$48.55 +0.80 (+1.68%)
As of 08/8/2025 07:09 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.

Sight Sciences stock logo

Sight Sciences NASDAQ:SGHT

$4.24 +0.69 (+19.44%)
Closing price 08/8/2025 04:00 PM Eastern
Extended Trading
$4.23 -0.01 (-0.24%)
As of 08/8/2025 04:18 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. It operates through two segments, Surgical Glaucoma and Dry Eye. The company's products include OMNI Surgical System, an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma; and SION Surgical Instrument, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. It also offers TearCare System, a wearable eyelid technology for adult patients with evaporative dry eye disease due to meibomian gland dysfunction, as well as related components. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. Sight Sciences, Inc. was incorporated in 2010 and is headquartered in Menlo Park, California.